Irvine (California) [US], January 21: Gene Solutions, a global biotechnology company, and Pangea Laboratory, a CLIA-certified, CAP-accredited Next Generation Sequencing (NGS) leader in validation platforms for Laboratory Developed Tests (LDTs), announced a strategic collaboration to advance
Washington [US], June 5 (ANI): Circulating tumor DNA (ctDNA) thats is a genetic material shed from tumors into the bloodstream can identify stage II colon cancer patients who can most benefit from chemotherapy following surgery and spare other patients the need for this form of treatment, ac